Bisoprolol Fumarate Tablets, Usp

Bisoprolol Fumarate Tablets, Usp
SPL v2
SPL
SPL Set ID 2d380e61-052c-4c33-8a35-01c9eb651d68
Route
ORAL
Published
Effective Date 2024-08-14
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Bisoprolol (5 mg)
Inactive Ingredients
Aluminum Oxide Anhydrous Dibasic Calcium Phosphate Butylated Hydroxyanisole Crospovidone (12 Mpa.s At 5%) D&c Yellow No. 10 Aluminum Lake Fd&c Red No. 40 Hypromellose 2910 (6 Mpa.s) Magnesium Stearate Microcrystalline Cellulose Polyethylene Glycol 6000 Silicon Dioxide Titanium Dioxide

Identifiers & Packaging

Pill Appearance
Imprint: 112 Shape: round Color: pink Color: white Size: 6 mm Size: 7 mm Score: 1
Marketing Status
ANDA Active Since 2022-09-15

Description

NDC 70771-1726-3 Bisoprolol Fumarate Tablets USP, 5 mg 30 Tablets Unit-of-Use Rx only NDC 70771-1727-3 Bisoprolol Fumarate Tablets USP, 10 mg 30 Tablets Unit-of-Use Rx only


Medication Information

Description

NDC 70771-1726-3 Bisoprolol Fumarate Tablets USP, 5 mg 30 Tablets Unit-of-Use Rx only NDC 70771-1727-3 Bisoprolol Fumarate Tablets USP, 10 mg 30 Tablets Unit-of-Use Rx only

Package Label.principal Display Panel

NDC 70771-1726-3

Bisoprolol Fumarate Tablets USP, 5 mg

30 Tablets

Unit-of-Use

Rx only

NDC 70771-1727-3

Bisoprolol Fumarate Tablets USP, 10 mg

30 Tablets

Unit-of-Use

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1726-3

Bisoprolol Fumarate Tablets USP, 5 mg

30 Tablets

Unit-of-Use

Rx only

NDC 70771-1727-3

Bisoprolol Fumarate Tablets USP, 10 mg

30 Tablets

Unit-of-Use

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)